Elsevier

Current Opinion in Immunology

Volume 38, February 2016, Pages 86-93
Current Opinion in Immunology

Innate lymphoid cells: parallel checkpoints and coordinate interactions with T cells

https://doi.org/10.1016/j.coi.2015.11.008Get rights and content

Highlights

  • The phenotypic and functional parallels between ILC and T cell subsets establish common immune checkpoints.

  • Complementarity and redundancy between ILCs and T cells ensures immune protection.

  • The immune function of ILCs are revealed in conditions of deficiencies of adaptive immunity.

Protection of epithelial and mucosal surfaces is required for survival. The recent discovery of a diverse array of innate lymphoid cells that lie immediately beneath these surfaces has unexpectedly uncovered an entire defense system distinct from the adaptive system essential to protect these barriers. This multilayered design provides a robust system through coupling of two highly complementary networks to ensure immune protection. Here, we discuss the similarities in the hardwiring and diversification of innate lymphoid cells and T cells during mammalian immune responses.

Introduction

Host immunity is composed of both the innate immune system and the adaptive immune system that form layered networks to defend the body against infection and maintain normal tissue homeostasis. Innate lymphoid cells (ILCs) are an expanding family of lymphocytes that lack somatically rearranged antigen specific receptors, produce significant amounts of cytokines and can be cytotoxic following activation. The distinct cytokines produced by each ILC subset are akin to the signature cytokines found for different CD4+ T helper cell (Th) subsets responding to their cognate antigens (Figure 1). Thus two apparently analogous systems have emerged allowing early responses initiated by ILCs to be coupled to T cell responses that ensure robust immunity and maintenance of host integrity.

Early work on ILCs has revealed striking similarities between the various subsets of ILCs and T cells [1] (Figure 1). These features include the shared expression of T-bet and IFN-γ by ILC1 and Th1 cells, GATA-3, IL-5 and IL-13 by ILC2 and Th2 cells, RORγt, IL-17 and IL-22 by ILC3 and Th17/Th22 cells as well as Eomes, IFN-γ and cytolytic molecules by CD8+ T cells and NK cells. Therefore, it has been tempting to speculate that ILCs could be considered as potential innate counterparts of T cells. The recent availability of ILC subset transcriptomic profiles [2] allowed us to further test this possibility by comparing them to the transcriptomic profiles of T cell subsets using principal component analysis. Based on the expression of 14 261 genes, the first component separates T cells from ILC (19% overall variability of the data set), showing that T cell subsets are more related to each other than they are to ILC subsets (Figure 2). The second component tends to separate natural killer (NK) cells, ILC1 and CD8+ T cells to ILC2, ILC3 and Th cells (14% overall variability of the data set). Contrary to the prevailing view, ILC1 are not related to Th1 but clearly defined as the opposite of Th1 cells on the first two components. This analysis illustrates the limits of the assimilation of ILCs to innate counterparts of T cells. Indeed, the relationships between ILCs and T cells appear numerous and complex. They include similarities, differences, cooperation and redundancy that will be reviewed here.

Section snippets

IL-15 is a common key factor for NK cells, ILC1 and CD8+ T cells

Cytotoxic lymphocytes are generally viewed as immune cells that can directly puncture the outer membrane of target cells (via Perforin) to deliver a toxic load of proteases (Granzyme B) resulting in apoptosis [3]. Transcriptomic profiles revealed that NK cells, ILC1 and CD8+ T cells all fit this description and express high levels of transcripts encoding these enzymes, as well as IFN-γ, whose production is another cardinal feature of cytotoxic cells.

IL-15 is a pleiotropic cytokine derived from

Articulation of the functions of ILC2s and Th2s

Group 2 ILC have been shown to be present at multiple sites including the spleen, liver, lung, intestinal lamina propria, skin, bone and adipose tissue. They have been shown to have an important role in early innate responses to helminth infections, in a variety of allergic inflammatory responses and in the maintenance of metabolic homeostasis. ILC2 are defined by their expression of the IL-33 receptor (IL-33R, or ST2) and transcriptional regulators Id2, Rorα, GATA3 and Bcl11b [31•, 32•, 33•, 34

Redundancy and complementarity of ILC3 and T cells

ILC3 are mainly associated with mucosal tissues where they can exert various functions. In the gut, ILC3 can be divided into two main subsets based on the cell surface expression of the natural cytotoxicity receptor (NCR) NKp46 (also referred as to NCR1 or CD335) in humans and mice [2•, 49]. However, ILC3 are more heterogenous as NCRILC3 include lymphoid-tissue inducer-like cells that express CCR6 and neuropilin 1 (Nrp1), and other NCRILC3 that can generate NCR+ILC3 via T-bet- and

Concluding remarks

The articulation between T and ILCs suggest that ILCs may contribute non-redundant functions when T cells are absent or not fully functional, prompting to dissect the role of ILCs during gestation, in newborns, in elderly as well as in conditions of immune-deficiency such as during viral infections or transplantation. In addition, there are a number of questions that remain to be addressed to fully appreciate the links between ILCs and T cells, such as:

  • what is the differential sensitivity of

Conflict of interests

E.V. is the cofounder and a shareholder of Innate Pharma. The other authors have no conflicting financial interest to declare.

References and recommended reading

Papers of particular interest, published within the period of review, have been highlighted as:

  • • of special interest

  • •• of outstanding interest

Acknowledgments

G.T.B. and N.H. laboratories are supported by grants and fellowships from the National Health and Medical Research Council (NHMRC) of Australia (G.T.B., N.H.) and the Australian Research Council (G.T.B.), the Victorian State Government Operational Infrastructure Support and the Australian Government NHMRC IRIIS. The EV laboratory is supported by the European Research Council (THINK Advanced Grant), the Ligue Nationale contre le Cancer (Equipe Labellisée) and by institutional grants from INSERM,

References (85)

  • L.C. Rankin et al.

    The transcription factor T-bet is essential for the development of NKp46+ innate lymphocytes via the Notch pathway

    Nat Immunol

    (2013)
  • S.A. van de Pavert et al.

    Differentiation and function of group 3 innate lymphoid cells, from embryo to adult

    Int Immunol

    (2015)
  • M. Cella et al.

    A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity

    Nature

    (2009)
  • C. Song et al.

    Unique and redundant functions of NKp46+ ILC3s in models of intestinal inflammation

    J Exp Med

    (2015)
  • R. Basu et al.

    Th22 cells are an important source of IL-22 for host protection against enteropathogenic bacteria

    Immunity

    (2012)
  • H. Ahlfors et al.

    IL-22 fate reporter reveals origin and control of IL-22 production in homeostasis and infection

    J Immunol

    (2014)
  • M.R. Hepworth et al.

    Innate lymphoid cells regulate CD4+ T-cell responses to intestinal commensal bacteria

    Nature

    (2013)
  • Y. Goto et al.

    Innate lymphoid cells regulate intestinal epithelial cell glycosylation

    Science

    (2014)
  • A. Mortha et al.

    Microbiota-dependent crosstalk between macrophages and ILC3 promotes intestinal homeostasis

    Science

    (2014)
  • S.H. Robbins et al.

    Novel insights into the relationships between dendritic cell subsets in human and mouse revealed by genome-wide expression profiling

    Genome Biol

    (2008)
  • H. Spits et al.

    Innate lymphoid cells – a proposal for uniform nomenclature

    Nat Rev Immunol

    (2013)
  • M.L. Robinette et al.

    Immunological Genome C: Transcriptional programs define molecular characteristics of innate lymphoid cell classes and subsets

    Nat Immunol

    (2015)
  • I. Voskoboinik et al.

    Perforin and granzymes: function, dysfunction and human pathology

    Nat Rev Immunol

    (2015)
  • N.D. Huntington et al.

    Interleukin 15-mediated survival of natural killer cells is determined by interactions among Bim, Noxa and Mcl-1

    Nat Immunol

    (2007)
  • N.D. Huntington

    The unconventional expression of IL-15 and its role in NK cell homeostasis

    Immunol Cell Biol

    (2014)
  • G. Verdeil et al.

    STAT5-mediated signals sustain a TCR-initiated gene expression program toward differentiation of CD8 T cell effectors

    J Immunol

    (2006)
  • M. Grange et al.

    Active STAT5 regulates T-bet and eomesodermin expression in CD8 T cells and imprints a T-bet-dependent Tc1 program with repressed IL-6/TGF-beta1 signaling

    J Immunol

    (2013)
  • P. Sathe et al.

    Innate immunodeficiency following genetic ablation of Mcl1 in natural killer cells

    Nat Commun

    (2014)
  • J.T. Opferman et al.

    Development and maintenance of B and T lymphocytes requires antiapoptotic MCL-1

    Nature

    (2003)
  • N.D. Huntington et al.

    IL-15 trans-presentation promotes human NK cell development and differentiation in vivo

    J Exp Med

    (2009)
  • T.A. Fehniger et al.

    Fatal leukemia in interleukin 15 transgenic mice follows early expansions in natural killer and memory phenotype CD8+ T cells

    J Exp Med

    (2001)
  • M.P. Rubinstein et al.

    IL-7 and IL-15 differentially regulate CD8+ T-cell subsets during contraction of the immune response

    Blood

    (2008)
  • K. Murali-Krishna et al.

    Cutting edge: naive T cells masquerading as memory cells

    J Immunol

    (2000)
  • A.W. Goldrath et al.

    Naive T cells transiently acquire a memory-like phenotype during homeostasis-driven proliferation

    J Exp Med

    (2000)
  • J.C. Sun et al.

    NK cell development, homeostasis and function: parallels with CD8(+) T cells

    Nat Rev Immunol

    (2011)
  • B.K. Cho et al.

    Homeostasis-stimulated proliferation drives naive T cells to differentiate directly into memory T cells

    J Exp Med

    (2000)
  • A. Marcais et al.

    The metabolic checkpoint kinase mTOR is essential for IL-15 signaling during the development and activation of NK cells

    Nat Immunol

    (2014)
  • K.N. Pollizzi et al.

    mTORC1 and mTORC2 selectively regulate CD8(+) T cell differentiation

    J Clin Invest

    (2015)
  • A. Fuchs et al.

    Intraepithelial type 1 innate lymphoid cells are a unique subset of IL-12- and IL-15-responsive IFN-gamma-producing cells

    Immunity

    (2013)
  • C.S. Klose et al.

    Differentiation of Type 1 ILCs from a common progenitor to all helper-like innate lymphoid cell lineages

    Cell

    (2014)
  • M.G. Constantinides et al.

    A committed precursor to innate lymphoid cells

    Nature

    (2014)
  • D. Gangadharan et al.

    Identification of pre- and postselection TCRalphabeta+ intraepithelial lymphocyte precursors in the thymus

    Immunity

    (2006)
  • Cited by (22)

    • A nonredundant role for T cell-derived interleukin 22 in antibacterial defense of colonic crypts

      2022, Immunity
      Citation Excerpt :

      Our findings address a central, unresolved issue regarding the coordination of innate and adaptive immunities and specialization of ILCs and CD4 T cells. Since the discovery of ILC subsets and appreciation of their functional parallel with T cell subsets (Bando and Colonna, 2016; Huntington et al., 2016; Song et al., 2015; Spits et al., 2013), it has been unclear what functions are unique to each immune cell population. Here, we find that despite their critical role in restraining bacterial colonization over the early course of enteropathogenic bacterial infection, ILC3s—and other IL-22-producing innate immune cells—induce weak STAT3 signaling that is limited to surface IECs.

    • Adoptive NK cell therapies in children with cancer: Clinical challenges and future possibilities

      2021, Successes and Challenges of NK Immunotherapy: Breaking Tolerance to Cancer Resistance
    • Regulation of neutrophils in type 2 immune responses

      2018, Current Opinion in Immunology
      Citation Excerpt :

      The distinction into different types of immune responses, such as type 1, type 2 and type 3 immunity, is perhaps best illustrated in CD4+ T cells, although other adaptive and innate immune cells also follow these patterns [1,2].

    • Innate Lymphoid Cells: Diversity, Plasticity, and Unique Functions in Immunity

      2018, Immunity
      Citation Excerpt :

      Thus, an important question is whether this ever increasing ILC diversity is actually due to multiple lineages of distinct subsets; in fact, a number of ILC phenotypes might reflect the adaptation of the same cell type to disparate tissue microenvironments, known as functional plasticity. Another important question concerns the redundancy of ILCs and T cells in immune responses, given that ILCs strikingly resemble T cells functionally and are perhaps equally malleable (Bando and Colonna, 2016; Huntington et al., 2016). Several studies have emphasized the distinct regulation, timing, duration, and magnitude of ILC and T cell primary immune responses.

    • Human γδ T cells: From a neglected lymphocyte population to cellular immunotherapy: A personal reflection of 30 years of γδ T cell research

      2016, Clinical Immunology
      Citation Excerpt :

      Apart from these conventional T cells which (together with B cells) constitute the adaptive “specific” immune system, various groups of unconventional lymphoid cells provide additional layers of cell mediated immunity. Such cells may (e.g., NKT cells, MAIT cells, γδ T cells) or may not (e.g., NK cells, ILC) express TCR molecules [55–60]. These unconventional lymphoid cells rapidly respond to stress- or infection-induced signals or cytokines and play a major role in local immune surveillance.

    • Insights into the tumor microenvironment of B cell lymphoma

      2022, Journal of Experimental and Clinical Cancer Research
    View all citing articles on Scopus
    View full text